Finding accredited CPD
Cervical cancer is a largely preventable disease in Australia. Primary prevention is achieved through vaccination against human papillomavirus (HPV) via the National HPV Vaccination Program, which aims to protect against oncogenic HPV types 16 and 18, responsible for approximately 70% of cervical cancers worldwide.
Secondary prevention is provided through the National Cervical Screening Program (NCSP), which detects and treats precancerous abnormalities before progression to invasive disease. Since December 2017, Australia has implemented five-yearly HPV testing for women and people with a cervix aged 25 to 74 years, replacing the previous two-yearly Pap test.
Cervical screening in Australia is delivered as part of primary healthcare, with general practitioners playing a critical role in screening, follow-up, and patient education.
The audit will seek to assist doctors with regards understanding the changed program and in transitioning their patients across. Changes in age eligibility, frequency of testing and understanding the incidence of HPV sub-types will be covered by this audit. Participation will also help to ensure that no patient is lost to follow up.
Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.
Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)